Reckitt Benckiser Group (LON:RB)‘s stock had its “overweight” rating reiterated by J P Morgan Chase & Co in a research report issued to clients and investors on Tuesday. They currently have a GBX 7,500 ($100.94) price objective on the stock. J P Morgan Chase & Co’s target price suggests a potential downside of 98.82% from the company’s previous close.
Other research analysts also recently issued reports about the company. UBS set a GBX 7,250 ($97.58) price target on Reckitt Benckiser Group and gave the company a “neutral” rating in a report on Wednesday, October 18th. Kepler Capital Markets reissued a “hold” rating and issued a GBX 7,300 ($98.25) price target on shares of Reckitt Benckiser Group in a report on Wednesday, October 18th. S&P Global set a GBX 7,500 ($100.94) price target on Reckitt Benckiser Group and gave the company a “neutral” rating in a report on Friday, October 20th. Societe Generale set a GBX 7,800 ($104.98) price target on Reckitt Benckiser Group and gave the company a “neutral” rating in a report on Tuesday, September 5th. Finally, Goldman Sachs Group decreased their price target on Reckitt Benckiser Group from GBX 8,130 ($109.42) to GBX 7,920 ($106.59) and set a “neutral” rating for the company in a report on Thursday, September 21st. Two investment analysts have rated the stock with a sell rating, twelve have given a hold rating and nine have assigned a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus target price of GBX 7,762.27 ($104.47).
Reckitt Benckiser Group (RB) opened at £6,361 ($8,561.24) on Tuesday. Reckitt Benckiser Group has a twelve month low of GBX 6,324 ($85.11) and a twelve month high of GBX 8,110.43 ($109.16).
In related news, insider Christopher Sinclair bought 2,800 shares of the company’s stock in a transaction on Wednesday, November 1st. The stock was bought at an average cost of GBX 6,597 ($88.79) per share, for a total transaction of £184,716 ($248,608.34). Also, insider Adrian Nevil Hennah bought 2,285 shares of the company’s stock in a transaction on Wednesday, November 8th. The stock was bought at an average price of GBX 6,567 ($88.38) per share, with a total value of £150,055.95 ($201,959.56).
TRADEMARK VIOLATION NOTICE: This story was published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this story on another domain, it was illegally copied and reposted in violation of United States and international copyright and trademark laws. The original version of this story can be accessed at https://www.dispatchtribunal.com/2017/12/05/reckitt-benckiser-group-rb-earns-overweight-rating-from-j-p-morgan-chase-co.html.
Reckitt Benckiser Group Company Profile
Reckitt Benckiser Group plc is a manufacturer and marketer of health, hygiene and home products. The Company’s segments include ENA and DvM. The ENA segment consists of Europe, Russia/Commonwealth of Independent States (CIS), Israel, North America, Australia and New Zealand. The DvM segment consists of North Africa, Middle East (excluding Israel) and Turkey, Africa, South Asia, North Asia, Latin America, Japan, Korea and the Association of Southeast Asian Nations (ASEAN).
Receive News & Ratings for Reckitt Benckiser Group Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group Plc and related companies with MarketBeat.com's FREE daily email newsletter.